International Business Times
6 November 2014
PA discusses the future of the NHS in International Business Times.
PA talks about the impact of intelligence and information on our ability to measure and improve our own health and how drug companies need to adapt to this new world.
According to PA, drug companies must become accountable for the outcomes of their concoctions rather just paid on input. He says: "We've got to stop paying for drugs on input but get the drug companies to look at outcomes and work with the health experts. But the bigger challenge is to transfer the burden of healthcare away from a centralised NHS and back to the patient."
For more information on how PA's government practice can support your organisation, click here or contact us now.